Kemper Claudia, Kolev Martin
MRC Centre for Transplantation, King's College, London, UK.
DTIMB, King's College, London, UK.
Bio Protoc. 2014 Aug 20;4(16). doi: 10.21769/BioProtoc.1205.
The complement component C3 is the major effector molecule of the complement system. C3 circulates in the blood and interstitial fluids as pro-enzyme and is activated by enzymatic cleavage into a C3a portion, a classic anaphylatoxin that functions as chemoattractant and immune cell activator, and the C3b portion, the body's most potent opsonin. C3 cleavage is in most cases mediated by an enzyme complex called the C3 convertase. However, it is now becoming increasingly clear that the cleavage of C3 by a range of 'single' proteases into bioactive C3a and C3b fragments is of high physiological significance. Here, we describe a protocol for the enzymatic cleavage of human C3 by the serine protease cathepsin L and the detection of the cleavage products C3a and C3b by western blotting as an example for this kind of enzymatic reactions.
补体成分C3是补体系统的主要效应分子。C3作为酶原在血液和组织液中循环,通过酶切被激活,裂解为C3a部分(一种经典的过敏毒素,起趋化因子和免疫细胞激活剂的作用)和C3b部分(机体最有效的调理素)。在大多数情况下,C3的裂解由一种称为C3转化酶的酶复合物介导。然而,现在越来越清楚的是,一系列“单一”蛋白酶将C3裂解为具有生物活性的C3a和C3b片段具有很高的生理意义。在此,我们描述了一种以丝氨酸蛋白酶组织蛋白酶L对人C3进行酶切,并通过蛋白质印迹法检测裂解产物C3a和C3b的方法,以此作为这类酶促反应的示例。